Orchestrates the end-to-end germline short-variant pipeline from FASTQ to a filtered, normalized, benchmarked VCF, chaining QC/trim, BWA-MEM2 alignment, duplicate marking, optional BQSR, calling (bcftools/GATK HaplotypeCaller/DeepVariant/DRAGEN), normalization, site+genotype filtering, annotation, and hap.py/vcfeval benchmarking. Use when deciding the pipeline-wide reference-genome commitment (GRCh38 analysis set vs T2T, ALT/decoy handling), sequencing the steps in the defensible order (normalize BEFORE annotate, filter site- then genotype-level), choosing the calling engine and single-sample vs cohort joint-calling, picking a filtering strategy by cohort size, or benchmarking stratified within GIAB confident regions. Hands off mechanism to the variant-calling and read-alignment component skills; not a re-teach of any single step.
Standardmäßig ist der Prompt ausgewählt, der zuerst die Quelle prüft. Sie können zu einem direkten Befehl wechseln oder eine lokale Kopie herunterladen.
Quelldateien prüfen
Lesen Sie SKILL.md und alle von SkillsMP angezeigten Begleitdateien, bevor Sie sich für eine Installation entscheiden.
Mit Codex oder Claude installieren Kopieren Sie diesen Prompt, fügen Sie ihn in Codex, Claude oder einen anderen Assistant ein und lassen Sie die Skill-Seite prüfen und installieren.
Ein direkter Befehl überspringt den Prüf-Prompt. Prüfen Sie die Quelle, bevor Sie ihn ausführen.
Orchestrates the end-to-end germline short-variant pipeline from FASTQ to a filtered, normalized, benchmarked VCF, chaining QC/trim, BWA-MEM2 alignment, duplicate marking, optional BQSR, calling (bcftools/GATK HaplotypeCaller/DeepVariant/DRAGEN), normalization, site+genotype filtering, annotation, and hap.py/vcfeval benchmarking. Use when deciding the pipeline-wide reference-genome commitment (GRCh38 analysis set vs T2T, ALT/decoy handling), sequencing the steps in the defensible order (normalize BEFORE annotate, filter site- then genotype-level), choosing the calling engine and single-sample vs cohort joint-calling, picking a filtering strategy by cohort size, or benchmarking stratified within GIAB confident regions. Hands off mechanism to the variant-calling and read-alignment component skills; not a re-teach of any single step.
[{"after_qc":"Q30 >85%, adapter content <1%"},{"after_alignment":"Mapping rate >95%, properly paired >90%"},{"after_dedup":"Duplication rate <30% for WGS, <50% for exome"},{"after_calling":"Ti/Tv ratio ~2.0-2.1 for WGS, ~3.0-3.3 for exome; dbSNP overlap >95% only after annotating the ID column"}]
Before using code patterns, verify installed versions match. If versions differ:
CLI: <tool> --version then <tool> --help to confirm flags
If code throws ImportError, AttributeError, or TypeError, introspect the installed
package and adapt the example to match the actual API rather than retrying.
Note: GenotypeGVCFs defaults (--max-alternate-alleles, --heterozygosity, --stand-call-conf), the GATK hard-filter thresholds, and DRAGEN speed/accuracy figures drift by version/vendor; confirm in-tool and against current GIAB benchmarks before quoting.
FASTQ to Variants Workflow
"Call variants from my whole-genome or exome FASTQ files" -> Chain QC/trim, alignment, duplicate marking, an engine-appropriate caller, normalization, filtering, annotation, and benchmarking into one filtered germline VCF.
This is a workflow skill: it owns the chaining decisions and hand-offs, not the internals of any one step. Every step below cross-references the component skill that teaches its mechanism.
The governing principle
A germline pipeline is a chain of commitments, and the two that decide whether the callset is trustworthy are made at the seams between steps, not inside them.
The reference is a pipeline-wide commitment made once and inherited by everything downstream. The build and analysis set chosen at alignment (step 2) fix the coordinates of every later comparison: the dbSNP/ClinVar/gnomAD records annotation matches against, the truth BED benchmarking scores within, and the cohort other samples are joint-called with must all be the SAME build. Changing it later means redoing alignment, calling, normalization, and annotation. Decide before aligning a single read.
The step order is not arbitrary; two orderings sink reviews. (a) Normalize BEFORE annotate. An indel that is not left-aligned to the database's canonical position is one base off, so the annotator silently misses the ClinVar/gnomAD record and reports a pathogenic variant as novel-absent -- a patient-safety failure that throws no error. (b) Never bcftools merge single-sample VCFs into a cohort. Absence of a record is then read as homozygous reference, fabricating genotypes; joint-genotype per-sample gVCFs instead so "confident hom-ref" is distinguished from "no data."
Filter site-level first, then genotype-level, then recompute cohort QC. Setting genotypes to no-call (./.) changes missingness, HWE, and allele frequencies, so those metrics must be computed on the genotype-filtered matrix, not before.
A single genome-wide F1 is nearly meaningless. Callers agree on easy SNPs (F1 > 0.999); they diverge in indels-in-repeats, segmental duplications, and MHC. Benchmark stratified, within the GIAB confident region, or do not claim accuracy (Krusche 2019 Nat Biotechnol 37:555-560).
Workflow overview
FASTQ
| [1] QC & trim -------------------> fastp (read-qc/fastp-workflow)
v
| [2] Align ----------------------> bwa-mem2 (read-alignment/bwa-alignment)
v ^-- reference commitment: GRCh38 analysis set / T2T, ALT/decoy handling
| [3] Mark duplicates ------------> samtools markdup (alignment-files/duplicate-handling)
v
| [4] (BQSR? optional on modern binned-quality instruments)
v
| [5] Call -----------------------> bcftools | GATK HaplotypeCaller | DeepVariant | DRAGEN
v ^-- single-sample OR per-sample gVCF -> joint-genotype (variant-calling/joint-calling)
| [6] Normalize (BEFORE annotate) -> bcftools norm -m-any -f ref (variant-calling/variant-normalization)
v
| [7] Filter: site-level THEN genotype-level (variant-calling/filtering-best-practices)
v
| [8] Recompute cohort QC on the genotype-filtered matrix (missingness, Ti/Tv, het/hom, excess-het HWE)
v
| [9] Annotate -------------------> VEP / SnpEff (variant-calling/variant-annotation)
v
| [10] Benchmark & QC ------------> hap.py/vcfeval, bcftools stats (variant-calling/vcf-statistics)
v
Filtered, normalized, benchmarked VCF
Reference genome: the pipeline-wide commitment
Decision made once, before alignment; everything downstream inherits it. Mechanism of building/indexing the reference lives in read-alignment/bwa-alignment; the deeper reasoning below is what a reviewer expects justified.
Choice
Commit to it when
Consequence inherited downstream
GRCh38 analysis set + decoys (hs38DH), ALT-aware (bwa-postalt)
Human germline, research or most clinical
Decoys soak up off-target reads; ALT-aware mapping recovers reads in MHC/segdup loci that ALT-unaware mapping force-fits to the primary, inflating false positives
Simpler and validated, but loses signal in ~5 Mb of ALT-bearing loci
Masked GRCh38 (false-duplication fix)
Calling in CBS, U2AF1, KCNE1B, KCNJ18 and other affected genes
Recovers reads whose mapQ collapsed across the phantom duplicate copy
T2T-CHM13
Research needing segdups/centromeres/dark genes; maximum accuracy
Reveals variants in newly resolved regions and removes GRCh38 false-duplication artifacts, but no lossless liftover to GRCh37/38, so the entire annotation/interpretation stack must be revalidated (Nurk 2022 Science 376:44-53; Aganezov 2022 Science 376:eabl3533)
The reason to fix this first: annotation databases, panel BEDs, benchmark truth sets, and any cohort a sample is joint-called with are all coordinate-specific. Mixing builds (e.g. normalizing to GRCh38 then annotating against a GRCh37 dbSNP) is a guaranteed silent miss. "We used GRCh38" is under-specified -- plain vs masked vs analysis-set-with-decoys materially changes results in named clinical genes.
The canonical order and why
Each step assumes the previous; the order is defensible under review (canonical preprocessing order, filtering/representation practice).
QC/trim -- remove adapters and low-quality tails before they corrupt alignment and duplicate detection.
Align -- to the committed reference, with read groups (SM/ID/PL/LB); read groups are a hard GATK requirement.
Mark duplicates -- PCR/optical duplicates are not independent evidence; marking (not removing) lets the caller down-weight them. Skip for amplicon/UMI data.
BQSR -- honestly optional on modern instruments. BQSR corrected context/cycle-dependent miscalibration on 2010-era continuous-quality Illumina. NovaSeq/NovaSeq X emit ~4 quality bins, leaving little to recalibrate; callsets are largely unchanged with vs without it. DeepVariant explicitly recommends NOT running BQSR (its CNN learned the raw-quality error model); DRAGEN handles quality internally (and uses DRAGSTR for STR/indel error modeling). Keep it for GATK-HaplotypeCaller consistency if a frozen pipeline demands it; otherwise the modern indel-accuracy lever is STR-aware error modeling (--dragen-mode), not BQSR.
Call -- per-sample VCF, or per-sample gVCF (-ERC GVCF) if a cohort will be joint-genotyped.
Normalize BEFORE annotate/compare -- bcftools norm -m-any -f ref.fa (split multiallelics, then left-align + parsimony), against the SAME reference used for annotation. Add -a (atomize) only when the downstream database is decomposed. This is the most common real ordering bug: annotate-then-normalize attaches consequences to a non-canonical representation that fails to match the database. The binding constraint is normalize-before-ANNOTATE/COMPARE, not normalize-before-filter: GATK convention runs VariantFiltration on the raw multiallelic records (its annotations are computed on that representation), then normalizes -- bwa_gatk_workflow.sh does exactly that, while bwa_bcftools_workflow.sh normalizes first. Both are correct; neither annotates before normalizing.
Filter site-level, then genotype-level -- site filters (VQSR/hard/ML) decide whether a site is real; genotype filters (GQ/DP/allele-balance) decide whether an individual genotype is trustworthy. SNPs and indels are filtered separately (different error processes and truth resources).
Recompute cohort QC on the genotype-filtered matrix -- missingness, Ti/Tv, het/hom, excess-het HWE. Doing HWE before genotype filtering lets low-GQ garbage drive spurious deviation.
Annotate on the normalized (and, where consequence matters, haplotype-resolved) representation.
Benchmark/validate after transforms (hap.py, bcftools stats).
Choosing the calling engine
Pipeline-level selection only; the mechanism and full decision table live in variant-calling/variant-calling. Hand off there to pick, then return here for chaining.
Situation
Lean toward
Hand off to
Auditable open-source, large cohort, joint calling
Maximum throughput on Illumina, hardware available
DRAGEN (or GATK --dragen-mode for the open equivalent)
variant-calling/variant-calling
Single-sample vs cohort is a chaining decision, not a caller feature. For a cohort, emit per-sample gVCFs and joint-genotype them so a variant seen in one sample is evaluated in all (cohort rescue of low-coverage hets, squared-off genotype matrix). This is what makes the pipeline forward-compatible with new samples (the N+1 problem). Full mechanism: variant-calling/joint-calling.
Primary path: BWA-MEM2 + bcftools
Fast, dependency-light, good for exploratory work and non-model organisms; weaker on indels in homopolymers than reassembly callers.
Read groups are mandatory; add -Y (soft-clip supplementary) if structural-variant calling is downstream, and -K 100000000 for thread-count-invariant output. Reference/analysis-set choice: read-alignment/bwa-alignment.
bwa-mem2 index reference.fa # once
bwa-mem2 mem -t 8 -K 100000000 \
-R "@RG\tID:sample\tSM:sample\tPL:ILLUMINA\tLB:lib1" \
reference.fa trimmed/sample_R1.fq.gz trimmed/sample_R2.fq.gz \
| samtools view -bS - > aligned/sample.bam
# collate groups mates by name; fixmate -m adds the ms/MC tags markdup needs; markdup needs coordinate order.# Do NOT coordinate-sort before fixmate, and do NOT markdup amplicon/PCR data (use UMIs there).
samtools collate -@ 8 -O -u aligned/sample.bam \
| samtools fixmate -m -@ 8 -u - - \
| samtools sort -@ 8 -u - \
| samtools markdup -@ 8 - aligned/sample.markdup.bam
samtools index aligned/sample.markdup.bam
Step 4: Call and normalize
# Single sample (mpileup passes MQ/BQ filters into the pileup)# -a FORMAT/DP,FORMAT/AD + call -f GQ emit the per-sample DP/GQ the Step 5 genotype filter needs.
bcftools mpileup -Ou -f reference.fa -a FORMAT/DP,FORMAT/AD --max-depth 250 --min-MQ 20 --min-BQ 20 \
aligned/sample.markdup.bam \
| bcftools call -mv -f GQ -Oz -o variants/sample.vcf.gz
# Normalize BEFORE any annotation or cross-callset comparison, against the SAME reference
bcftools norm -m-any -f reference.fa -Oz -o variants/sample.norm.vcf.gz variants/sample.vcf.gz
bcftools index variants/sample.norm.vcf.gz
For multi-sample cohorts, bcftools can call several BAMs jointly, but the GATK/DeepVariant gVCF path is preferred at scale (variant-calling/joint-calling).
Step 5: Filter (site then genotype)
# Site-level (bcftools flags rather than removes, so failures stay auditable)
bcftools filter -Oz -s LowQual \
-e 'QUAL<20 || INFO/DP<10 || MQ<30' \
-o variants/sample.siteflt.vcf.gz variants/sample.norm.vcf.gz
# Genotype-level: set low-confidence genotypes to no-call (NOT 0/0)
bcftools filter -Oz -S . \
-e 'FMT/GQ<20 | FMT/DP<8' \
-o variants/sample.filtered.vcf.gz variants/sample.siteflt.vcf.gz
bcftools index variants/sample.filtered.vcf.gz
Alternative path: BWA-MEM2 + GATK HaplotypeCaller
Local reassembly + PairHMM; the auditable reference implementation, strong on indels. Full mechanism: variant-calling/gatk-variant-calling.
The site-level filter is chosen by cohort size, platform, and organism; genotype-level filtering is always applied on top. Full mechanism and thresholds: variant-calling/filtering-best-practices.
Cohort / data
Site-level filter
Why
Large WGS cohort (~30+ jointly genotyped)
VQSR (or AS_VQSR for huge cohorts)
The Gaussian-mixture model needs tens of thousands of variants and truth-resource overlap to fit; unreliable below that
Single sample / small cohort
GATK hard filters or VETS/NVScoreVariants
VQSR is non-identifiable on few variants; a "converged" model on one exome is filtering on noise
Exome specifically
Hard filters (do NOT use DP as a VQSR annotation)
Capture-boundary coverage cliffs break the annotation manifold
Non-model organism
Hard filters or a bootstrapped truth set
No HapMap/Omni/Mills truth resources exist
DeepVariant / DRAGEN output
Use the caller's own calibration; do NOT re-apply GATK hard filters
Their error modes differ; classic annotations do not describe them
SNPs and indels are filtered separately (different error processes, truth resources, abundance). Hard-filter starting points (SNPs QD<2, FS>60, MQ<40, MQRankSum<-12.5, ReadPosRankSum<-8, SOR>3; indels loosen FS>200, tighten ReadPosRankSum<-20) are lenient heuristics to tune, not universal truth. RankSum annotations are only defined at het sites -- a hand-written filter must treat a missing annotation as PASS, or every hom-alt site vanishes.
Benchmarking the pipeline
Goal: a defensible accuracy statement, not a single number.
The only rigorous way to compare a callset to truth is haplotype-aware, stratified, and confined to the truth set's confident region. Two VCFs can encode the identical haplotype with different records, so a naive bcftools isec/line-diff overcounts errors; use hap.py wrapping the vcfeval engine, which replays variants onto the reference and matches at the haplotype level (Krusche 2019 Nat Biotechnol 37:555-560; GIAB truth, Zook 2019 Nat Biotechnol 37:561-566).
# Only meaningful when the sample IS a GIAB genome (HG001-HG007) with a truth VCF + confident BED.# -f = confident/callable region BED (TP/FP/FN counted ONLY inside it; calls outside are UNK, not FP)
hap.py truth.vcf.gz query.norm.vcf.gz \
-f HG002_confident.bed \
-r reference.fa \
-o bench/hg002 \
--engine=vcfeval \
--stratification stratification.tsv # GIAB region BEDs: low-complexity, segdup, MHC, GC-extreme
Discipline that separates a senior benchmark from a naive one:
Refuse the global F1. Report SNP and INDEL separately, and show the low-complexity/segmental-duplication/MHC rows explicitly -- hiding them behind an all-regions average is the most common soft cheat.
Do not benchmark an ML caller only on its training genome. DeepVariant and DRAGEN-ML train on GIAB coordinates, so scoring on HG002 alone partly measures memorization; score on a held-out or semi-blinded sample (HG003/HG004).
"We found variants GIAB missed" is almost always a category error -- calls outside the confident region, which GIAB declined to adjudicate, not accuracy. Real hard-region claims cite CMRG or an assembly-based benchmark.
When the sample is not a GIAB genome (the usual case), there is no truth VCF; fall back to proxy QC -- Ti/Tv (~2.0-2.1 WGS, ~3.0-3.3 exome), dbSNP overlap, het/hom by ancestry, and trio Mendelian concordance if a family is available. These are proxies for the absence of a benchmark, not a substitute for one (variant-calling/vcf-statistics).
Ti/Tv sliding toward 0.5 (random) signals false-positive inflation -- filters too loose. bcftools stats counts known sites from the ID column, and callers leave it as .: run bcftools annotate -c ID -a dbsnp.vcf.gz first or the dbSNP-overlap line reads 0% regardless of quality
Common Errors
Symptom
Cause
Fix
Annotation reports a known pathogenic variant as novel/absent
Annotated before normalizing; indel one base off the database coordinate
bcftools norm -m-any -f ref against the SAME build as the annotation DB, BEFORE annotation
Cohort has impossible all-hom-ref genotypes at variant sites
Built the cohort by bcftools merge of single-sample VCFs
Emit per-sample gVCFs and joint-genotype (variant-calling/joint-calling)
Every hom-alt site filtered out
Hand-written filter treats missing RankSum as failing
Treat missing annotation as PASS; RankSum is defined only at het sites
VQSR "converged" on one exome but the callset is garbage
VQSR needs tens of thousands of variants across ~30+ samples
Use hard filters or VETS/NVScoreVariants for single samples/exomes
Spurious variants in CBS/U2AF1/KCNE1B
GRCh38 false duplications collapse mapQ
Use a masked GRCh38 or T2T-CHM13; commit the reference before calling
GATK error "sample ... has no read group"
Read groups omitted at alignment
Re-run bwa-mem2 mem -R "@RG\t..." (SM/ID/PL/LB)
Different variant counts from vt vs bcftools on the same data
vt decomposes MNPs by default, bcftools does not
Standardize ONE normalization tool + flags across every cohort compared (variant-calling/variant-normalization)
Pipeline map (hand-offs)
read-qc/fastp-workflow -- QC/trim options and report interpretation
variant-calling/variant-calling - Engine selection and bcftools calling options
variant-calling/gatk-variant-calling - GATK HaplotypeCaller and DRAGEN mode
variant-calling/deepvariant - Deep-learning calling and GLnexus cohorts
variant-calling/joint-calling - Cohort joint genotyping and scaling
variant-calling/variant-normalization - Normalize before annotate/compare
variant-calling/filtering-best-practices - VQSR, hard filters, VETS
variant-calling/variant-annotation - Annotate variants with VEP
variant-calling/vcf-statistics - Ti/Tv, het/hom, and identity QC
References
Krusche P, Trigg L, Boutros PC, et al. (GA4GH Benchmarking Team). Best practices for benchmarking germline small-variant calls in human genomes. Nature Biotechnology 37:555-560 (2019). DOI 10.1038/s41587-019-0054-x. Stratified haplotype-aware benchmarking (hap.py/vcfeval).
Zook JM, McDaniel J, Olson ND, et al. An open resource for accurately benchmarking small variant and reference calls. Nature Biotechnology 37:561-566 (2019). DOI 10.1038/s41587-019-0074-6. GIAB truth set + confident regions.
DePristo MA, Banks E, Poplin R, et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nature Genetics 43:491-498 (2011). DOI 10.1038/ng.806. GATK framework.
Van der Auwera GA, Carneiro MO, Hartl C, et al. From FastQ Data to High-Confidence Variant Calls: The Genome Analysis Toolkit Best Practices Pipeline. Current Protocols in Bioinformatics 43:11.10.1-11.10.33 (2013). DOI 10.1002/0471250953.bi1110s43.
Poplin R, Ruano-Rubio V, DePristo MA, et al. Scaling accurate genetic variant discovery to tens of thousands of samples. bioRxiv 201178 (2018). DOI 10.1101/201178. Preprint only (never journal-published); the GVCF/joint-genotyping reference.
Poplin R, Chang P-C, Alexander D, et al. A universal SNP and small-indel variant caller using deep neural networks. Nature Biotechnology 36:983-987 (2018). DOI 10.1038/nbt.4235. DeepVariant.
Yun T, Li H, Chang P-C, et al. Accurate, scalable cohort variant calls using DeepVariant and GLnexus. Bioinformatics 36:5582-5589 (2020). DOI 10.1093/bioinformatics/btaa1081.
Danecek P, Bonfield JK, Liddle J, et al. Twelve years of SAMtools and BCFtools. GigaScience 10:giab008 (2021). DOI 10.1093/gigascience/giab008.
Nurk S, Koren S, Rhie A, et al. The complete sequence of a human genome. Science 376:44-53 (2022). DOI 10.1126/science.abj6987. T2T-CHM13.
Aganezov S, Yan SM, et al. A complete reference genome improves analysis of human genetic variation. Science 376:eabl3533 (2022). DOI 10.1126/science.abl3533. Reference-choice variant-calling payoff.
